(Q37901020)

25 August 2017

1 reference

title

The role of CD40/CD40L and interferon regulatory factor 4 in Hodgkin lymphoma microenvironment (English)

1 reference

25 August 2017

1 reference

Donatella Aldinucci

1

1 reference

25 August 2017

Annunziata Gloghini

2

1 reference

25 August 2017

Antonio Pinto

3

1 reference

25 August 2017

Alfonso Colombatti

4

1 reference

25 August 2017

Antonino Carbone

5

1 reference

25 August 2017

publication date

24 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

53

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

195-201

1 reference

Cancer-related inflammation

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

The biology of Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

IRF4 is modulated by CD40L and by apoptotic and anti-proliferative signals in Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

The Germinal centre-derived lymphomas seen through their cellular microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Biology and clinical applications of CD40 in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

CD40 regulates the processing of NF-kappaB2 p100 to p52

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

21 January 2018

NF-κB in immunobiology.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

The role of interleukin-3 in classical Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

CD40-ligation-mediated protection from apoptosis of a Fas-sensitive Hodgkin's-disease-derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Frequent inactivation of A20 in B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

LMP1 structure and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Expression of CCL5 (RANTES) and CCR5 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

IRF4: Immunity. Malignancy! Therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

IRF4 addiction in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.605190

10.3109/10428194.2011.605190

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference